1997
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60
Xenos E, Ciancio G, Burke G, Roth D, Miller J. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Clinical Transplantation 1997, 11: 497-499. PMID: 9361949, DOI: 10.1111/j.1399-0012.1997.tb01032.x.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAge FactorsAgedAzathioprineCadaverCyclosporineFemaleGlucocorticoidsGraft RejectionHumansImmunosuppressive AgentsInfusions, IntravenousKidney Failure, ChronicKidney TransplantationMaleMethylprednisoloneMiddle AgedMuromonab-CD3Mycophenolic AcidTacrolimusTreatment OutcomeConceptsMaintenance immunosuppressionOutcome of kidney transplantationTacrolimus-based therapyMaintenance immunosuppressive regimensEnd-stage renal diseaseImmediate postoperative periodCadaveric transplant recipientsRate of rejectionAntilymphocyte preparationsImmunosuppressive regimensInduction regimenMycophenolate mofetilRescue therapyRenal recipientsTransplant recipientsRenal transplantationAntibody inductionPostoperative periodTreatment optionsKidney transplantationTacrolimusRenal diseaseRS-61443MycophenolateAge groups
1993
Cytokine changes in thrombotic thrombocytopenic purpura following kidney transplantation
Burke G, Cirocco R, Carreno M, Pardo V, Roth D, Castillo A, Temple J, Esquenazi V, Milgrom M, Miller J. Cytokine changes in thrombotic thrombocytopenic purpura following kidney transplantation. Clinical Transplantation 1993, 7: 47-51. DOI: 10.1111/j.1399-0012.1993.tb00875.x.Peer-Reviewed Original ResearchThrombotic thrombocytopenic purpuraKidney transplantationThrombocytopenic purpuraIL-2Occurrence of thrombotic thrombocytopenic purpuraSerum levels of interleukin-2Levels of IL-2Levels of interleukin-2Endothelial cells in vitroCells in vitroSevere neurological changesSteroid administrationClinical improvementCytokine changesSerum levelsIFN-gInterleukin-2Gamma interferonGamma-IFNPatient seraTransplantationNeurological changesKidneyPurpuraPatients